Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

NCT01970098 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01970098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01970098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Lead sponsor
Kissei Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
October 9, 2013
Completion date
January 31, 2015
Enrollment
374 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinocerebellar degeneration